Hillevax Inc (HLVX)

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Track Share on 𝕏

Stock chart
Ticker: HLVX Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-05-03 2024-05-03 PS Planned sale

Kohli Aditya

Non-Executive Director
723 -0.1%
14.15
10,233 USD 		723 -0.1% 14.15 10,233 USD
2024-05-03 2024-05-02 PS Planned sale

Kohli Aditya

Non-Executive Director
6,000 -0.8%
14.01
84,081 USD 		6,000 -0.8% 14.01 84,081 USD
2024-05-03 2024-05-01 PS Planned sale

Kohli Aditya

Non-Executive Director
175 -0.0%
14.03
2,456 USD 		175 -0.0% 14.03 2,456 USD
2024-04-05 2024-04-05 PS Planned sale

Kohli Aditya

Non-Executive Director
6,000 -0.8%
14.44
86,640 USD 		6,000 -0.8% 14.44 86,640 USD
2024-04-08 2024-04-04 B Purchase

Frazier Life Sciences X, L.P.

Large shareholder
8,850 +0.1%
14.50
128,325 USD 		8,850 +0.1% 14.50 128,325 USD
2024-04-05 2024-04-04 PS Planned sale

Kohli Aditya

Non-Executive Director
6,000 -0.7%
14.71
88,245 USD 		6,000 -0.7% 14.71 88,245 USD
2024-04-05 2024-04-03 PS Planned sale

Kohli Aditya

Non-Executive Director
6,000 -0.7%
14.93
89,582 USD 		6,000 -0.7% 14.93 89,582 USD
2024-04-01 2024-03-28 B Purchase

McLoughlin Sean

Chief Operating Officer

Officer
1,250 +inf%
16.98
21,225 USD 		1,250 +inf% 16.98 21,225 USD
2024-03-20 2024-03-20 PS Planned sale

Kohli Aditya

Non-Executive Director
6,000 -0.7%
164,221.00
985,326,000 USD 		6,000 -0.7% 164,221.00 985,326,000 USD
2024-03-20 2024-03-19 PS Planned sale

Kohli Aditya

Non-Executive Director
6,000 -0.7%
17.42
104,492 USD 		6,000 -0.7% 17.42 104,492 USD
2024-03-20 2024-03-18 PS Planned sale

Kohli Aditya

Non-Executive Director
6,000 -0.7%
17.66
105,937 USD 		6,000 -0.7% 17.66 105,937 USD
2024-03-08 2024-03-08 PS Planned sale

Kohli Aditya

Non-Executive Director
6,000 -0.7%
18.66
111,959 USD 		6,000 -0.7% 18.66 111,959 USD
2024-03-08 2024-03-07 PS Planned sale

Kohli Aditya

Non-Executive Director
6,000 -0.7%
18.37
110,213 USD 		6,000 -0.7% 18.37 110,213 USD
2024-03-08 2024-03-06 PS Planned sale

Kohli Aditya

Non-Executive Director
6,000 -0.7%
18.95
113,701 USD 		6,000 -0.7% 18.95 113,701 USD
2024-02-22 2024-02-22 PS Planned sale

Kohli Aditya

Non-Executive Director
6,000 -0.7%
15.05
90,312 USD 		6,000 -0.7% 15.05 90,312 USD
2024-02-22 2024-02-21 PS Planned sale

Kohli Aditya

Non-Executive Director
6,000 -0.7%
14.92
89,495 USD 		6,000 -0.7% 14.92 89,495 USD
2024-02-22 2024-02-20 PS Planned sale

Kohli Aditya

Non-Executive Director
6,000 -0.7%
14.88
89,272 USD 		6,000 -0.7% 14.88 89,272 USD
2024-02-14 2024-02-12 PS Planned sale

Kohli Aditya

Non-Executive Director
6,000 -0.7%
15.32
91,921 USD 		6,000 -0.7% 15.32 91,921 USD
2024-02-12 2024-02-08 S Sale

Borkowski Astrid

Chief Medical Officer

Officer
3,933 -2.4%
14.93
58,726 USD 		3,933 -2.4% 14.93 58,726 USD
2024-02-12 2024-02-08 S Sale

HERSHBERG ROBERT

See Remarks

Executive Director
11,597 -1.2%
14.93
173,161 USD 		11,597 -1.2% 14.93 173,161 USD
2024-02-12 2024-02-08 S Sale

Kohli Aditya

Non-Executive Director
8,866 -1.1%
14.93
132,383 USD 		8,866 -1.1% 14.93 132,383 USD
2024-02-12 2024-02-08 S Sale

Maltbie Shane

Chief Financial Officer

Officer
3,576 -8.1%
14.93
53,395 USD 		3,576 -8.1% 14.93 53,395 USD
2023-12-18 2023-12-15 S Sale

Borkowski Astrid

Chief Medical Officer

Officer
10,000 -5.7%
15.50
155,000 USD 		10,000 -5.7% 15.50 155,000 USD
2023-12-05 2023-12-04 S Sale

Borkowski Astrid

Chief Medical Officer

Officer
10,000 -5.4%
14.50
145,000 USD 		10,000 -5.4% 14.50 145,000 USD
2023-12-05 2023-12-01 S Sale

Borkowski Astrid

Chief Medical Officer

Officer
10,000 -5.1%
14.20
142,000 USD 		10,000 -5.1% 14.20 142,000 USD
2023-11-20 2023-11-17 S Sale

Borkowski Astrid

Chief Medical Officer

Officer
10,000 -4.9%
14.00
140,000 USD 		10,000 -4.9% 14.00 140,000 USD
2023-11-13 2023-11-08 S Sale

Borkowski Astrid

Chief Medical Officer

Officer
5,000 -2.4%
13.00
65,000 USD 		5,000 -2.4% 13.00 65,000 USD
2022-05-03 2022-05-03 B Purchase

Frazier Life Sciences X, L.P.

Large shareholder
1,764,706 +26.1%
17.00
30,000,002 USD 		1,764,706 +26.1% 17.00 30,000,002 USD